This inventor holds 1 USPTO granted patent. Top assignee: Schweiz Serum & Impfinstitut Bern. Active years: 1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996
Title: Reinhard Glück: Innovator in Hepatitis A Virus Research
Introduction
Reinhard Glück is a notable inventor based in Spiegel, Bern, Switzerland. He has made significant contributions to the field of virology, particularly in the study of hepatitis A viruses. His work has implications for vaccine development and diagnostic methods.
Latest Patents
Reinhard Glück holds a patent for a new hepatitis A virus strain, specifically the RG-SB XA112 (CNCM I-1080). This invention relates to hepatitis A viruses (HAVs) that exhibit unique immunological characteristics. The patent also covers methods for isolating these HAVs, which can be utilized in the production of vaccines and diagnostic compositions. Additionally, the invention includes polyclonal and monoclonal antibodies directed towards the new HAVs.
Career Highlights
Reinhard Glück is associated with the Schweiz Serum & Impfinstitut Bern, where he conducts research and development in the field of infectious diseases. His work has been instrumental in advancing our understanding of hepatitis A and its potential treatments.
Collaborations
Reinhard collaborates with various professionals in his field, including his coworker Stefan Brantschen. Their combined expertise contributes to the ongoing research and development efforts at their institution.
Conclusion
Reinhard Glück's innovative work in hepatitis A virus research highlights the importance of scientific advancements in public health. His contributions pave the way for future developments in vaccines and diagnostic tools.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile